Stockscreener 앱 받기
0.4251
5.98%
0.024
시간 외 거래:
.43
0.0049
+1.15%
20 20 Biolabs Inc 주식(AIDX)의 최신 뉴스
20/20 BioLabs meets potential partners in East Asia - Investing.com
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy - The Manila Times
20/20 Biolabs, Inc. Revenue Breakdown – NASDAQ:AIDX - TradingView
20/20 Biolabs, Inc. (AIDX) stock price, news, quote and history - Yahoo Finance UK
Rokit Healthcare, US 20/20 BioLabs to Co-Develop AI Multi-Cancer Prediction Platform - Seoul Economic Daily
20/20 BioLabs enters standstill pact on preferred stock - Investing.com
20/20 BioLabs Enters Temporary Standstill Agreement Limiting Series E Preferred Stock Conversions - Quiver Quantitative
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock - The Manila Times
Press Release: 20/20 BioLabs Announces Standstill Agreement With Streeterville Capital Regarding Series E Convertible Preferred Stock - Moomoo
20/20 Biolabs, Inc. Signs Standstill Agreement With Streeterville Capital – SEC 8-K Filing Details (July 2026) - Minichart
20/20 Biolabs Received Notice of Noncompliance - TradingView
20/20 Biolabs (Nasdaq: AIDX) signs standstill as Nasdaq flags bid-price issue - Stock Titan
Why Super Micro Computer Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
What Factors Led to 20/20 Biolabs' Dramatic Stock Collapse - Kavout | AI
20/20 BioLabs reports Q2 MCED revenue to be highest to date - Investing.com
20/20 BioLabs highlights OneTest™ strategy for Medicare coverage and reports strong Q2 revenue growth - Pluang
20/20 BioLabs Highlights Investor Webinar Focused on - GlobeNewswire
Virax Biolabs | 20-F: Registration statement / Annual report / Transition report - Moomoo
AIDX SEC Filings20/20 Biolabs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
20/20 Biolabs (AIDX) Jumps Nearly 5% as Stock Approaches Key $0.67 ResistanceIchimoku Cloud - dars.gov.et
20/20 Biolabs to present OneTest webinar outlining Medicare pathway, modeling and reimbursement plan - TradingView
OneTest growth vision: 20/20 Biolabs (AIDX) targets Medicare MCED market - Stock Titan
20/20 BioLabs’ Multi-Cancer Early Detection Test Now Available to Evexia Diagnostics' 40,000+ U.S. Practitioners - The National Law Review
20/20 Biolabs Inc. (AIDX) Edges Higher in Low-Price Territory as Support HoldsWyckoff Spring - dars.gov.et
20/20 Biolabs, Inc. Actuals & Estimates (NASDAQ:AIDX) - TradingView
Price to sales forward of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
Price to book forward of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
Price to earnings forward of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
AIDX | 20/20 Biolabs, Inc. Common Executive Compensation - Quiver Quantitative
Large share authorization and new equity plan up for 20/20 Biolabs (AIDX) vote - Stock Titan
20/20 BioLabs Bets on Radical Transparency with Monthly Investor Calls - BriefGlance
20/20 BioLabs Launches Monthly Investor Webinar Series to Enhance Shareholder Communication - Quiver Quantitative
20/20 BioLabs starts monthly webinars, with a OneTest discount for attendees - Stock Titan
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month - GlobeNewswire
20/20 Biolabs, Inc.(NasdaqCM: AIDX) added to S&P TMI Index - marketscreener.com
AIDX Price Today: 20/20 Biolabs, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Meet Greater Washington's newest publicly traded companiesWashington Business Journal - The Business Journals
AIDX - Finviz
20/20 Biolabs Inc. (AIDX) Surges 13.6%: Breaking Out on Heavy VolumeSign of Strength - dars.gov.et
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Gapping stocks in Monday's session - ChartMill
10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Tower Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Trending Stocks Today | Aspire Biopharma up 6.03% Post-Market - Moomoo
Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill
20/20 Biolabs (AIDX) Surges 10.86%: Key Levels and Market SentimentETF AUM Growth - newsline.com
20/20 Biolabs (AIDX) Dips 7.75% – Key Support Test in FocusFactor Crowding - newsline.com
20/20 Biolabs (AIDX) Slumps 7.75% as Stock Nears Key $0.76 Support LevelFactor Rotation - newsline.com
Director Kathryn Gregory exits Longevity Health Holdings (XAGE) board without dispute - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
20/20 Biolabs (NASDAQ: AIDX) asks shareholders to raise authorized shares to 500M - Stock Titan
20/20 Biolabs, Inc. Files Form 8-K Announcing Amended and Restated Bylaws and Nasdaq Listing as Emerging Growth Company - Minichart
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters - The Manila Times
20/20 Biolabs' OneTest™ Selected for Vermont Firefighter Cancer Screening Initiative, Expected to Generate $500,000 in Revenue - Quiver Quantitative
20/20 Biolabs, Inc.Common Stock (Nasdaq:AIDX) Stock Quote - The Chronicle-Journal
1.04%
11.95%
자본화:
|
볼륨(24시간):